SCHEDULE 13G/A: BlackRock Discloses 6.6% Stake in SPYRE THERAPEUTICS INC
Beneficial Ownership Report
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.6% beneficial ownership stake in SPYRE THERAPEUTICS INC's common stock.
Summary
- BlackRock, Inc. reported beneficial ownership of 3,962,635 shares of SPYRE THERAPEUTICS INC common stock.
- This aggregate amount represents 6.6% of the total outstanding common stock of SPYRE THERAPEUTICS INC.
- BlackRock, Inc. holds sole voting power over 3,869,094 shares and sole dispositive power over 3,962,635 shares.
- No shared voting or dispositive power was reported.
- The filing was made under Rule 13d-1(b) of the Securities Exchange Act of 1934, indicating the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The disclosure of a significant institutional stake by BlackRock is generally viewed as a positive signal, indicating a large asset manager's confidence in the company. However, the filing itself is purely informational and does not contain performance or forward-looking statements from the company.
Positives
- A significant stake by a major institutional investor like BlackRock may signal confidence in SPYRE THERAPEUTICS INC's future prospects.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may view BlackRock's significant stake as a positive indicator of institutional confidence in SPYRE THERAPEUTICS INC.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of execution for the Power of Attorney granted by BlackRock, Inc. |
| 06/30/2025 | Date of event which required the filing of this statement. |
| 07/16/2025 | Date of filing of this Schedule 13G. |
Keywords
BlackRock, SPYRE THERAPEUTICS INC, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Equity Stake, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.